Dr Matthias Evers steps down as Chief Business Officer effective 01 October 2024Distribution of responsibilities across other Management Board functions HAMBURG, GERMANY / ACCESSWIRE / September 3, ...
AEVIS VICTORIA SA (AEVS.SW) – Klinik Pyramide to be integrated into Privatklinik Bethanien in Zurich
AEVIS VICTORIA SA (AEVS.SW) – Klinik Pyramide to be integrated into Privatklinik Bethanien in Zurich ...
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Zurich, 3rd of September 2024: Xlife Sciences AG (SIX: XLS) today ...
The government must use its autumn budget to tackle the NHS' mounting financial crisis or risk health leaders having to make further service and staffing cuts and there not being enough capacity in ...
Track and trace solutions provider to help businesses meet NAFDAC regulations ACG Inspection, a leading track and trace solutions provider for the pharmaceutical industry, is pleased to announce that ...
According to a comprehensive market analysis by Future Market Insights (FMI), the global 3D reconstruction technology market is on a trajectory of substantial growth. Valued at approximately USD 1,164 ...
Mohib Rahmani, Managing Principal at operations transformation consultancy Argon & Co highlights the steps that pharmaceutical firms can take to optimise their inventories, unlock substantial stock ...
The global antimicrobial wound care dressings market is on a robust growth trajectory, according to recent market analysis. Forecasts indicate that the market demand will reach USD 1.38 billion by ...
In a groundbreaking market analysis by Future Market Insights, the global chronic brain damage management market is projected to experience significant growth over the next decade. The market, ...
EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces today it has ...
Corporate ActionMarinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights02-Sep-2024 / 17:46 CET/CESTDisclosure of an inside information acc. to ...
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved a strategic investment into Tanvex Biopharma Co., Ltd. ("Tanvex", TWSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback